CNS Disorders  >>  Symlin (pramlintide) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
DTAD, NCT03560960: Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Recruiting
1
240
US
Pramlintide challenge test, Symlin
Boston University, National Institute on Aging (NIA)
Alzheimer Disease, Mild Cognitive Impairment
03/25
11/26

Download Options